trending Market Intelligence /marketintelligence/en/news-insights/trending/nrjccwum0pg7ffqjk5odma2 content esgSubNav
In This List

Humanigen appoints chief medical officer

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Humanigen appoints chief medical officer

Brisbane, Calif.-based Humanigen Inc. named Tarek Sahmoud as its chief medical officer.

Sahmoud consults a number of chimeric antigen receptor T cell therapy companies on their clinical and regulatory plans.

He recently served as the chief medical officer for Eisai Co. Ltd.'s unit H3 Biomedicine Inc., a biopharmaceutical company engaged in the discovery and development of small-molecule drugs to treat cancer.

Humanigen is developing CAR-T optimization and cancer treatments.